lifestyle.thedailyhaze.com

Author: Panome Bio

Panome Bio and Audubon Bioscience Partner to Deliver End-to-End FFPE Biospecimen and Metabolomics Solutions for Cancer Researchers

April 16, 2026
Panome Bio Launches Exposomics Services to Measure the Chemical Drivers of Human Disease

March 5, 2026
Panome Bio Introduces MassID™, a Major Advance in Untargeted Metabolomics Data Analysis for Biomarker Discovery and Drug Development

February 25, 2026